2019 | 2020 | P Value | ||||
---|---|---|---|---|---|---|
# Number of Patients | % | # Number of Patients | % | |||
Number of Patients | 43,667 | 34,130 | ||||
Age Cohorts | < 40 | 869 | 2.00% | 695 | 2.00% | 0.122 |
40–44 | 774 | 1.80% | 611 | 1.80% | ||
45–49 | 1558 | 3.60% | 1141 | 3.30% | ||
50–54 | 2969 | 6.80% | 2376 | 7.00% | ||
55–59 | 5374 | 12.30% | 4212 | 12.30% | ||
60–64 | 7391 | 16.90% | 5756 | 16.90% | ||
65–69 | 7969 | 18.20% | 6489 | 19.00% | ||
70–74 | 7440 | 17.00% | 5797 | 17.00% | ||
75–79 | 4987 | 11.40% | 3794 | 11.10% | ||
80–84 | 2817 | 6.50% | 2081 | 6.10% | ||
85 + | 1519 | 3.50% | 1178 | 3.50% | ||
Gender | female | 23,742 | 54.40% | 18,368 | 53.80% | 0.299 |
male | 19,925 | 45.60% | 15,762 | 46.20% | ||
Race | American Indian or Alaska Native | 163 | 0.40% | 152 | 0.40% | < 0.001 |
Asian | 594 | 1.40% | 709 | 2.10% | ||
Black or African American | 3636 | 8.30% | 3013 | 8.80% | ||
Native Hawaiian or Pacific Islander | 74 | 0.20% | 75 | 0.20% | ||
Some Other Race | 0 | 0.00% | 32 | 0.10% | ||
Unknown/Not Reported | 10,442 | 23.90% | 7339 | 21.50% | ||
White | 28,758 | 65.90% | 22,810 | 66.80% | ||
BMI Category | < 18.5 | 331 | 0.80% | 290 | 0.90% | 0.241 |
18.5–24.9 | 7648 | 17.60% | 6129 | 18.10% | ||
25.0–29.9 | 14,465 | 33.30% | 11,092 | 32.80% | ||
30.0–34.9 | 11,635 | 26.80% | 9078 | 26.80% | ||
35.0–39.9 | 6233 | 14.30% | 4871 | 14.40% | ||
40.0 + | 3124 | 7.20% | 2399 | 7.10% | ||
Diabetes mellitus | Insulin Dependent | 1282 | 2.90% | 966 | 2.80% | 0.632 |
No | 38,263 | 87.60% | 29,910 | 87.60% | ||
Non-Insulin Dependent | 4122 | 9.40% | 3254 | 9.50% | ||
Current smoker | No | 38,621 | 88.40% | 30,291 | 88.80% | 0.181 |
Yes | 5046 | 11.60% | 3839 | 11.20% | ||
Dyspnea | At Rest | 52 | 0.10% | 37 | 0.10% | 0.007 |
Moderate Exertion | 2001 | 4.60% | 1405 | 4.10% | ||
No | 41,614 | 95.30% | 32,688 | 95.80% | ||
Functional health status | Independent | 42,755 | 97.90% | 33,431 | 98.00% | < 0.001 |
Partially Dependent | 570 | 1.30% | 557 | 1.60% | ||
Totally Dependent | 25 | 0.10% | 37 | 0.10% | ||
Unknown | 317 | 0.70% | 105 | 0.30% | ||
History of Severe COPD | No | 42,026 | 96.20% | 32,923 | 96.50% | 0.103 |
Yes | 1641 | 3.80% | 1207 | 3.50% | ||
Congestive heart failure (CHF) | No | 43,483 | 99.60% | 33,986 | 99.60% | 0.991 |
Yes | 184 | 0.40% | 144 | 0.40% | ||
Hypertension | No | 19,743 | 45.20% | 15,543 | 45.50% | 0.362 |
Yes | 23,924 | 54.80% | 18,587 | 54.50% | ||
Currently on dialysis (pre-op) | No | 43,588 | 99.80% | 34,057 | 99.80% | 0.301 |
Yes | 79 | 0.20% | 73 | 0.20% | ||
Steroid use for chronic condition | No | 42,170 | 96.60% | 32,955 | 96.60% | 0.912 |
Yes | 1497 | 3.40% | 1175 | 3.40% | ||
> 10% loss body weight in last 6 months | No | 43,583 | 99.80% | 34,053 | 99.80% | 0.311 |
Yes | 84 | 0.20% | 77 | 0.20% | ||
Bleeding disorders | No | 42,917 | 98.30% | 33,491 | 98.10% | 0.106 |
Yes | 750 | 1.70% | 639 | 1.90% | ||
mFI | 0 | 18,162 | 41.60% | 14,278 | 41.80% | 0.625 |
1 | 19,707 | 45.10% | 15,309 | 44.90% | ||
2 | 5384 | 12.30% | 4205 | 12.30% | ||
3 | 386 | 0.90% | 319 | 0.90% | ||
4 | 25 | 0.10% | 19 | 0.10% | ||
5 | 3 | 0.00% | 0 | 0.00% | ||
Inpatient/Outpatient | Inpatient | 41,162 | 94.30% | 21,977 | 64.40% | < 0.001 |
Outpatient | 2505 | 5.70% | 12,153 | 35.60% | ||
ASA classification | 1-No Disturbance | 1419 | 3.20% | 1004 | 2.90% | 0.012 |
2-Mild Disturbance | 22,179 | 50.80% | 17,310 | 50.70% | ||
3-Severe Disturbance | 19,273 | 44.10% | 15,101 | 44.20% | ||
4-Life Threat | 759 | 1.70% | 690 | 2.00% | f | |
Principal anesthesia technique | Epidural | 266 | 0.60% | 222 | 0.70% | < 0.001 |
General | 17,782 | 40.70% | 13,149 | 38.50% | ||
MAC/IV Sedation | 8963 | 20.50% | 7962 | 23.30% | ||
Regional | 509 | 1.20% | 663 | 1.90% | ||
Spinal | 16,111 | 36.90% | 12,109 | 35.50% | ||
Other | 36 | 0.08% | 25 | 0.07% | ||
Total operation time (minutes) | 89.81 | 91.65 | < 0.001 | |||
Length of hospital stay (days) | 1.78 | 1.55 | < 0.001 |